Netflix (NFLX) gained 2.25 million domestic subscribers in the first quarter of fiscal 2014. This brings its total to 35.7 million. The company provides Internet television network service that enables subscribers to stream TV shows and movies directly on devices in the United States and internationally. Netflix operates in the domestic streaming, international streaming, and domestic DVD segments. The company also offers standard definition DVDs and Blue-ray discs to its subscribers in the United States. It is headquartered in Los Gatos, California and was founded in 1997.
Numbers at a Glance Netflix has been working to improve its quality of service from a technical point of view. In its first quarter financial results, the company reported earnings of 86 cents per share on revenues of $1.27 billion. Netflix�� earnings were above analyst expectations of 83 cents a share, while the company�� revenue was in line with the $1.27 billion Wall Street analysts forecast for the quarter. In the first quarter of 2013, Netflix earned 5 cents a share on $1 billion in revenue.
5 Best Cheap Stocks To Buy For 2015: Rouse Properties Inc (RSE)
Rouse Properties, Inc. (Rouse), incorporated on August 10, 2011, is a real estate investment trust (REIT) company. Rouse is engaged in the operation, development and management of retail rental property. The Company�� portfolio consists of 30 regional malls in 19 states totaling over 21 million square feet of retail and ancillary space. The Company is a regional mall owner in the United State. It manages all of its properties, performing the day-to-day functions, operations, leasing, maintenance, marketing and promotional services. Its malls are anchored by operators across the retail spectrum. The Company�� regional malls include Sikes Senter Mall, Valley Hills Mall, Bayshore Mall and The Boulevard Mall. Its portfolio also includes regional malls that have growth through lease-up, repositioning and redevelopment. Rouse is a wholly owned subsidiary of GGP Limited Partnership (GGPLP), which is majority owned by General Growth Properties, Inc. (GGP). In February 2012, the Company purchased Grand Traverse Mall in Traverse City. In January 2013, the Company acquired the Mall at Turtle Creek and an adjacent shopping center, Turtle Creek Crossing. In July 2013, the Company announced the acquisition of Greenville Mall, in Greenville, North Carolina. In December 2013, the Company acquired Chesterfield Towne Center, in Richmond, Virginia, and the Centre at Salisbury, in Salisbury, Maryland.
The operators across the retail spectrum, including departments stores, such as Macy's, JC Penney, Sears, Dillard's, Walmart and Target; mall shop tenants, such as Hollister, Victoria's Secret, Bath & Body Works, Aeropostale, American Eagle, Children's Place, Gap/Old Navy, Footlocker, Maurices and Forever 21; restaurants ranging from food court, such as Sarku Japan, Panda Express and Chick Fil A; casual chains, such as Chipotle, Panera Bread and Starbucks, and sit down restaurants, including On The Border, Buffalo Wild Wings, Red Robin and multiple Darden concepts.
Advisors' Opinion:- [By Mike Arnold]
Brookfield's public assets include a 21% stake (and potentially more given certain warrants held by Brookfield) in General Growth Properties (GGP), a 51% stake in Brookfield Office Properties (BPO), a 36% stake (again, more if certain warrants are exercised) in Rouse Properties (RSE) and 21% stake in Canary Wharf Group Plc, which is majority owned by Songbird Estates Plc (SBEPF.PK).
Top 10 Quality Stocks To Watch For 2014: Novo Nordisk A/S (NVO)
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products in Denmark and internationally. The company operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes care segment covers insulins, oral antidiabetic drugs, and other protein-related products and projects comprising glucagon and protein-related delivery systems, as well as GLP-1 analogue. The Biopharmaceuticals segment provides products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation therapy. Its products are marketed and distributed through subsidiaries, distributors, and independent agents in 180 countries. Novo Nordisk A/S has a collaboration agreement with Archimedes, Inc. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
Advisors' Opinion:- [By Sean Williams]
The end of the week didn't bring good tidings for shareholders of Novo Nordisk (NYSE: NVO ) , which, according to a report from BioCentury, received a second complete response letter (i.e., a rejection letter) from the FDA for its recombinant Factor XIII therapy to treat a form of hemophilia. According to the report, the rejection is based on unresolved issues at Novo Nordisk's manufacturing facility and merely adds to a series of struggles the company has had with regard to advancing its hemophilia-related pipeline. As you might expect, Novo Nordisk is working with the FDA to resolve this issue as quickly as possible.�
- [By Rich Duprey]
What started with the Food Network not renewing her TV show contract has now turned into a complete rout, with major corporations including Wal-Mart (NYSE: WMT ) , Target, Home Depot, and Novo Nordisk (NYSE: NVO ) all dropping their association with her.
- [By Bryan Murphy]
The advent of stem cell biotechnology has put several diseases and ailments in the crosshairs... cancer, multiple sclerosis, arthritis, and even brain injuries, just to name a few. There are no limits to what cell-based therapies could do, however, with the right ingenuity and know-how. That's how a small cap, off-the-radar company called BioRestorative Therapies, Inc. (OTCBB:BRTX) may be about to make life much more difficult for bigger diabetes players like Johnson & Johnson (NYSE:JNJ) and Novo Nordisk A/S (NYSE:NVO).
- [By EP Vantage]
Novo Nordisk (NVO) has chalked up a second big miscalculation in 2013. Losing purchasing contracts with the US pharmacy benefit manager (PBM) Express Scripts after raising prices this year for its premium diabetes products will be another hit to its bottom line, and limit access to Victoza and Novolog for about 155 million privately insured Americans.
Top 10 Quality Stocks To Watch For 2014: GTSI Corp.(GTSI)
GTSI Corp., together with its subsidiaries, provides information technology (IT) hardware and solutions to federal, state, and local government customers, as well as to prime contractors in the United States. It offers IT infrastructure solutions, including data center consolidation and optimization solutions, server and desktop virtualization solutions, cloud computing solutions, network modernization solutions, unified communications and collaboration solutions, database and software development solutions, asset management solutions, and financial services solutions. The company also provides various services comprising software development and maintenance, program and project management, database development and maintenance, and legacy systems modernization services. In addition, it offers computer hardware, software, and peripheral products, as well as provides technical support and assistance services. The company markets and sells its computer hardware and software, and solutions through GTSI.com. It has strategic partner relationships with Cisco, Hewlett Packard, Crossmatch Technologies, Microsoft, Dell, Oracle, Net App, and Hitachi. GTSI Corp. was founded in 1983 and is headquartered in Herndon, Virginia.
Advisors' Opinion:- [By Geoff Gannon]
Someone who reads my articles sent me this question: My��uestion has to do with the type of investments you tend to put your energy toward. Evaluating a net-net is a whole lot different than evaluating a company that has a competitive advantage and trades at much higher multiples. To me, the net-net evaluation process is a whole lot more straightforward, as there are fewer intangibles (if any) and less prediction about the future involved. I don't have to worry about whether GTSI (GTSI) has any competitive advantage ��I know it doesn't. Then again, I look at a company like Becton Dickenson (BDX) and I see a highly predictable company with a decent moat selling at a reasonable price. I can look at BDX and figure I might earn 10-15% annually over a long time frame. That's really different from thinking about investing in a net-net where I can see how it's 30-50% undervalued now, but it's not something I'm going to hold onto for decades. It's more of a matter of waiting for that one-time "pop" that will happen sometime in the next 1-5 years. How do you decide where to put your energy?
Top 10 Quality Stocks To Watch For 2014: Cadence Pharmaceuticals Inc.(CADX)
Cadence Pharmaceuticals, Inc., a biopharmaceutical company, focuses on acquiring, in-licensing, developing, and commercializing proprietary product candidates principally for use in the hospital setting in the United States and Canada. It holds rights to OFIRMEV injection, a proprietary intravenous formulation of acetaminophen for the management of pain and reduction of fever in adults and children. The company in-licenses rights to OFIRMEV from Bristol-Myers Squibb Company, which sells intravenous acetaminophen in Europe and other markets for the treatment of acute pain and fever under the Perfalgan brand name. Cadence Pharmaceuticals, Inc. was founded in 2004 and is headquartered in San Diego, California.
Advisors' Opinion:- [By Paul Ausick]
Stocks on the Move: Zulily Inc. (NASDAQ: ZU) is up 71.4% at $37.70 after its IPO today. Cadence Pharmaceuticals Inc. (NASDAQ: CADX) is up 33.8% at $7.87 on a patent ruling. Electronic Arts Inc. (NASDAQ: EA) is down 7.4% at $24.04.
- [By Jake L'Ecuyer]
Equities Trading UP
Cadence Pharmaceuticals (NASDAQ: CADX) shot up 26.42 percent to $14.02 after Mallinckrodt plc (NYSE: MNK) announced its plans to acquire Cadence Pharma for $14.00 per share in cash.
Top 10 Quality Stocks To Watch For 2014: Revolution Lighting Technologies Inc (RVLT)
Revolution Lighting Technologies Inc., incorporated on December 16, 1993, designs, manufacture, market and sells commercial grade, light emitting diode (LED) replacement light bulbs and LED-based signage, channel letter and contour lighting products. The Company sells these products under the Seesmart, Array Lighting and Lumificient brand names. The Company operates in two segments: LED replacement lamps and fixtures and LED signage and lighting strips. On December 20, 2012, the Company acquired Seesmart Technologies, Inc., headquartered in Simi Valley, California. In August 2013, the Company announced that it has completed the acquisition of Relume Technologies (Relume). In October 2013, the Company announced that it has acquired a portfolio of general illumination LED lighting products, including several product lines from CMG Energy Solutions (CMG). In November 2013, the Company acquired Tri-State LED.
The Company�� LED replacement lamps and fixtures segment include the Seesmart business and the Array business, which has been integrated with the Seesmart business. The LED signage and lighting strips segment is comprised of the Lumificient business.
Advisors' Opinion:- [By Roberto Pedone]
Another under-$10 stock that's starting to move within range of triggering a big breakout trade is Revolution Lightning Technologies (RVLT), which designs, manufactures, markets and sells, commercial grade, LED replacement lamps, LED fixtures and LED-based signage, channel-letter and contour lighting products. This stock has been a monster for the bulls so far in 2013, with shares up a whopping 445%.
If you take a look at the chart for Revolution Lightning Technologies, you'll notice that this stock has recently formed a double bottom chart pattern at $2.19 to $2.22 a share. Following that bottom, shares of RVLT exploded to the upside and hit a recent high of $3.96 a share with strong upside volume flows. Shares of RVLT are now finding some buying interest right around its 50-day moving average of $3.36 a share. If that level can hold, then RVLT will set up to resume its uptrend and potentially trigger another big breakout trade.
Market players should now look for long-biased trades in RVLT if it manages to break out above some near-term overhead resistance levels at $3.70 to $3.80 a share and then above more resistance at $3.96 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 1.21 million shares. If that breakout triggers soon, then RVLT will set up to re-test or possibly take out its next major overhead resistance levels at $4.94 to $5.50 a share.
Traders can look to buy RVLT off weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average at $3.36 a share, or around $3 a share. One can also buy RVLT off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Paul Ausick]
Big Earnings Movers: The Walt Disney Co. (NYSE: DIS) is up 2.1% at $68.58 on a good showing for its films but not so much for its TV programming. Molycorp Inc. (NYSE: MCP) is up 1.8% at $4.85 after offering a weakish outlook. Revolution Lighting Technologies Inc. (NASDAQ: RVLT) is up 21.5% at $3.28 after a strong report and reaffirmed solid outlook.
- [By Paul Ausick]
Without making too much fuss over a small-cap stock, Revolution Lighting Technologies Inc. (NASDAQ: RVLT) is seeing its share price rise by nearly 25% today after reporting results this Friday morning. Yahoo! Finance does not have any estimates for the company, but Revolution posted an operating loss of $3.1 million in the quarter, more than four times worse than its loss in the same period in 2012. Even with adjustments Revolution�� operating loss totaled $1.8 million.
Top 10 Quality Stocks To Watch For 2014: Ormat Technologies Inc.(ORA)
Ormat Technologies, Inc., together with its subsidiaries, engages in the geothermal and recovered energy power business in the United States and internationally. The company operates in two segments, Electricity and Product. The Electricity segment develops, builds, owns, and operates geothermal and recovered energy-based power plants; and sells the electricity. The Product segment designs, manufactures, and sells power units for geothermal and recovered energy-based electricity generation; fossil fuel powered turbo-generators; and heavy duty direct-current generators. It also provides services relating to the engineering, procurement, construction, operation, and maintenance of geothermal and recovered energy power plants. This segment serves contractors and geothermal power plant owners and operators; and interstate natural gas pipeline owners and operators, gas processing plant owners and operators, cement plant owners and operators, and companies in other energy-intens ive industrial processes. The company was founded in 1965 and is based in Reno, Nevada. Ormat Technologies, Inc. is a subsidiary of Ormat Industries Ltd.
Advisors' Opinion:- [By John Udovich]
Small cap Ocean Power Technologies Inc (NASDAQ: OPTT) just sank 34% on news that they have fired their CEO "for cause,��meaning its worth taking a closer look at the stock to see if there is anything to salvage (shares were rising more than 6% in after hours) plus take a look at the performance of potential renewable energy related peers like Ormat Technologies, Inc (NYSE: ORA), Broadwind Energy Inc (NASDAQ: BWEN) and China Ming Yang Wind Power Group Ltd (NYSE: MY).
- [By Marie Mawad]
Orange SA (ORA), France�� biggest phone company, agreed to sell its Dominican Republic unit to Altice, a cable and telecommunications investor, for $1.4 billion.
Top 10 Quality Stocks To Watch For 2014: Arena Pharmaceuticals Inc.(ARNA)
Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing oral drugs in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company?s clinical development programs include lorcaserin that has completed two pivotal Phase III clinical trials for the treatment of weight management, including weight loss and maintenance of weight loss; and APD811, which is under Phase I clinical trial for the treatment of pulmonary arterial hypertension. Its preclinical development programs include APD334, for the treatment of autoimmune diseases, including multiple sclerosis and rheumatoid arthritis. The company also researches and develops cannabinoid, receptor agonists for the treatment of osteoarthritis and pain; and GPR119 agonists for the treatment of type 2 diabetes. Its other development programs, which had completed Phase I clinical trial include APD597 for th e treatment of type II diabetes; APD916 for the treatment of narcolepsy and cataplexy; and APD791 for the treatment of arterial thrombosis. In addition, the company provides manufacturing services. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California.
Advisors' Opinion:- [By John Udovich]
Orexigen Therapeutics, Inc (NASDAQ: OREX), like Arena Pharmaceuticals, Inc (NASDAQ: ARNA), EnteroMedics Inc (NASDAQ: ETRM) and VIVUS, Inc (NASDAQ: VVUS), is a speculative small cap obesity drug stock that has the potential for coming up with the next big thing in the treatment of obesity that is increasingly a global problems. I should mention that we have recently added Orexigen Therapeutics to our SmallCap Network Elite Opportunity (SCN EO) portfolio as an extremely speculative biotech bet because its�lead obesity drug candidate has the potential to be�approved by September 11th of this year.
No comments:
Post a Comment